Event Brief
High-dose vitamin B3 may slow aggressive brain cancer
Filed: Mar 31, 2026 at 6:02 PM ET
Summary: A study suggests high-dose vitamin B3 could enhance immune function and slow glioblastoma progression in patients.
WHO: Researchers at the University of Calgary
WHAT: Study on high-dose vitamin B3's effects on glioblastoma
WHEN: Mar 31, 2026 at 5:29 PM ET
WHERE: Canada
WHY: To determine if high-dose vitamin B3 can improve disease control in glioblastoma patients.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →